Advertisement

Intelligent Bio Solutions Inc. INBS

Set alert

Price alert · INBS

All alert types
1.66 USD -0.06 -3.49%

As of Nov 2, 3:03 PM ET

Bid
1.66 × 2
Ask
1.72 × 2
1.66 Day range 1.80
1.35 52-week range 24.90
YTD
-82.58%
1 year
-83.01%
Open
1.80
Prev close
1.72
Mkt cap
5.51M
Vol
23.43K
Avg vol
143.73K
EPS
-8.44
P/E
0.00
Div yield
0.00%
More statistics
Low
1.66
High
1.80
Forward P/E
3.83
Beta
4.72
Short ratio
1.25
Inst. own
14.38%
Dividend
0.00
Ex-div date
Earnings
Feb 14, 2025
50-d avg
1.53
200-d avg
2.07
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Nov 7, 2024Earnings: -0.7; estimate 0; surprise —%
  • Feb 14, 2025Earnings: —; estimate 0; surprise —%
  • Dec 16, 2025Split: 1 for 10
Signals (70)
NameDateAgo
MACD: Buy SignalOct 16, 20262 weeks ago
RSI: OversoldOct 8, 20263 weeks ago
RSI: OversoldOct 6, 20263 weeks ago
RSI: OversoldSep 28, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BullishSep 9, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Sell SignalAug 26, 20262 months ago
RSI: OverboughtAug 17, 20262 months ago
SMA: BullishAug 12, 20262 months ago
RSI: OverboughtAug 12, 20262 months ago
MACD: Buy SignalAug 4, 20263 months ago
RSI: OversoldJul 24, 20263 months ago
RSI: OversoldJul 21, 20263 months ago
MACD: Sell SignalJul 20, 20263 months ago
MACD: Buy SignalJun 26, 20264 months ago
MACD: Sell SignalJun 25, 20264 months ago
MACD: Buy SignalJun 22, 20264 months ago
MACD: Sell SignalMay 22, 20265 months ago
SMA: BearishMay 20, 20265 months ago
RSI: OverboughtMay 13, 20265 months ago
SMA: BullishMay 11, 20265 months ago
RSI: OversoldApr 2, 20267 months ago
RSI: OversoldMar 18, 20267 months ago
MACD: Buy SignalMar 2, 20268 months ago
RSI: OversoldFeb 23, 20268 months ago
SMA: BearishFeb 2, 20269 months ago
SMA: BearishJan 21, 20269 months ago
MACD: Sell SignalJan 21, 20269 months ago
RSI: OverboughtJan 13, 20269 months ago
SMA: BullishJan 8, 20269 months ago
RSI: OverboughtJan 8, 20269 months ago
SMA: BullishDec 31, 202510 months ago
MACD: Buy SignalDec 31, 202510 months ago
RSI: OversoldDec 29, 202510 months ago
MACD: Sell SignalDec 23, 202510 months ago
MACD: Buy SignalDec 18, 202510 months ago
MACD: Sell SignalDec 16, 202510 months ago
RSI: OversoldDec 12, 202510 months ago
MACD: Buy SignalNov 24, 202511 months ago
RSI: OversoldNov 13, 202511 months ago
RSI: OversoldNov 6, 202512 months ago
MACD: Sell SignalNov 5, 202512 months ago
MACD: Buy SignalOct 14, 20251 year ago
MACD: Sell SignalSep 18, 20251 year ago
SMA: BearishSep 17, 20251 year ago
SMA: BearishSep 17, 20251 year ago
SMA: BullishSep 9, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BearishAug 29, 20251 year ago
SMA: BullishAug 28, 20251 year ago
MACD: Buy SignalAug 22, 20251 year ago
SMA: BearishJul 25, 20251 year ago
MACD: Sell SignalJul 25, 20251 year ago
MACD: Buy SignalJul 16, 20251 year ago
MACD: Sell SignalJun 24, 20251 year ago
RSI: OverboughtJun 10, 20251 year ago
SMA: BullishMay 28, 20251 year ago
MACD: Buy SignalApr 22, 20251 year ago
RSI: OversoldApr 16, 20251 year ago
RSI: OversoldApr 4, 20251 year ago
RSI: OversoldMar 31, 20251 year ago
SMA: BearishMar 25, 20251 year ago
MACD: Sell SignalFeb 25, 20251 year ago
RSI: OverboughtFeb 6, 20251 year ago
RSI: OverboughtJan 31, 20251 year ago
SMA: BullishJan 29, 20251 year ago
MACD: Buy SignalJan 17, 20251 year ago
MACD: Sell SignalJan 13, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago

Key statistics

Market cap
5.88M
Enterprise value
769.49K
Trailing P/E
0.00
Forward P/E
3.83
PEG ratio
0.00
Price / sales
1.89
Price / book
0.56
EPS (TTM)
-2.30
Beta
4.72
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
3.11M
Revenue growth
64.20%
Free cash flow
-5.87M
Total cash
6.42M
Total debt
871.44K
Return on equity
-171.71%
Shares outstanding
4.39M
Short % of float
8.73%
50-day average
1.53
200-day average
2.07

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Feb 14, 2025

Expected Feb 14, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
INBS Revenue — quarterly 1.39M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
INBS Net income — quarterly -3.91M
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026
INBS EPS — quarterly -0.90
2023-Q1 20222023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 2026

Earnings

INBS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 14, 2025Dec 1, 20240.00———
Nov 7, 2024Sep 1, 20240.00-0.70——
Sep 19, 2024Jun 1, 20240.00———
May 8, 2024Mar 1, 20240.00———
May 8, 2024Mar 1, 20240.00-1.43——
Feb 9, 2024Dec 1, 2023-3.24———

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse. It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
ibs.inc

News

Your note

Sign in to keep a note on INBS — it syncs with the Stock Master app.

Insider holders

INBS insider holders
InsiderRelationLatest transactionDateShares held
SAKIRIS SPIRO KEVINChief Financial OfficerStock Award(Grant)Sep 24, 202453,759
SIMEONIDIS HARRYChief Executive OfficerStock Award(Grant)Sep 24, 202440,408
TOWERS CHRISTOPHERDirectorPurchaseOct 3, 20239,880

Institution ownership

INBS institution ownership
Holder% heldSharesValueReported
Alyeska Investment Group, L.p.4.70%206,199276.31KSep 29, 2024
CVI Holdings, LLC1.82%79,843106.99KJun 29, 2024
Geode Capital Management, LLC0.52%22,70630.43KSep 29, 2024
Vanguard Group Inc0.35%15,48520.75KSep 29, 2024
Adar1 Capital Management, LLC 0.12%5,3897.22KSep 29, 2024
UBS Group AG0.04%1,5512.08KSep 29, 2024

Fund ownership

INBS fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.40%17,64123.64KOct 30, 2024
Vanguard Extended Market Index Fund0.35%15,48520.75KSep 29, 2024
Fidelity Series Total Market Index Fund0.13%5,5997.50KOct 30, 2024
Fidelity Total Market Index Fund0.09%4,0975.49KOct 30, 2024
Advertisement